Matches in SemOpenAlex for { <https://semopenalex.org/work/W61151033> ?p ?o ?g. }
- W61151033 abstract "Background: Despite great advantages in cancer therapeutics during the last decades, therapy-resistance remains a problem in the majority of malignancies. Hence, development of more effective therapeutics is critical to enhance survival of patients with cancer. A big challenge for therapy development is low efficacy upon clinical translation; therapies proven highly effective in animal trials often exhibit a poor effect or even fail in the clinic. This indicates the need for more relevant preclinical in vivo model systems for cancer. Malignant melanoma and pediatric neuroblastoma, occurring in derivatives of the neural crest, are both exhibiting a high degree of therapy-resistance, with a high number of deaths as a consequence. These malignancies are characterized by a significant plastic developmental capacity with a tumour phenotype extensively depending on the surrounding microenvironment. Thus, they provide excellent opportunity for studies on interactions between the tumour and adjacent supportive tissue. Objective: The overall aim of this thesis is to optimize and validate a human in vivo model system, based on human embryonic stem cell derived teratomas (hEST-model), for growth and progression of neural crest derived malignancies. Further on, I aim to elucidate whether human tumours grafted in such system are having a higher resemblance to clinical tumours, as compared to conventionally used xenografts. Results: Based on a thorough kinetic study of development in hESC derived teratoma from the cell line HS181, we chose day 45 as the time point for tumour inoculation. At this time, mature embryonic tissues are formed and human vascularisation is initiated. Also, this allows further grafting of the tumour cells without affecting the animals wellbeing and occurrence of necrotic areas. The capacity for teratoma formation was also explored using a subline of HS181 with altered karyotype, i.e. trisomic for chromosome 12. Results revealed that these cells are capable of forming teratomas, however with a skewed tissue contribution with higher frequency of renal formation. Cell lines from malignant melanoma and neuroblastomas were grafted in the hEST-model and compared to the corresponding xenograft. For the melanomas, striking differences in expression of markers related to melanocytic differentiation was seen, indicative of induced differentiation from the xenograft-environment. Also, a dedifferentiated and invasive subpopulation of melanoma cells was detected, but not present in the xenograft, indicating species-specific interactions upon migration and invasion into surrounding stroma. Grafting of three different neuroblastoma cell lines in the hESTmodel resulted in a general finding of higher histological heterogeneity and more resemblance to clinical neuroblastomas, as compared to the xenografts. Grafting of both tumour types in the hEST-model induced an extensive neo-vascularisation of human origin in the surrounding mesenchyme indicating species-specific effects. Conclusions: The results presented in this thesis indicate that a human in vivo model system for cancer based on hESC-derived teratomas add significant importance for preclinical cancer studies. The embryonic environment of the teratoma is probably most relevant for grafting of embryonic tumours, indicated also by our results using pediatric neuroblastoma. Altogether, the hEST-model provides unique possibilities to study human tumours in a species-specific environment, and is therefore suggested a well-needed complement to current preclinical in vivo models. LIST OF PUBLICATIONS I. Gertow, K.*, Cedervall, J.*, Jamil, S., Imreh, M.P., Ali, R., Gulyas, M., Sandstedt, B., Ahrlund-Richter, L. Early and late events in xenograft development from the human Embryonic Stem Cell line HS181 Resemblance with an initial multiple epiblast formation followed by a chaotic embryonic organoid development. Submitted II. Gertow, K., Cedervall, J., Unger, C., Szoke, K., Blennow, E., Imreh, M.P., Ahrlund-Richter, L. Trisomy 12 in hESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J Cell Biochem 2007; 100(6): 1518-1525. III. Cedervall, J., Jamil, S., Prasmickaite, L., Cheng, Y.F., Eskandarpour, M., Hansson, J., Maelandsmo, G.M., Ringborg, U., Gulyas, M., Suo, Z., Kanter, L., Ahrlund-Richter, L. Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts. Cancer Res 2009; 69: 3746-3754. IV. Cedervall, J., Jamil, S., Hultman, I., Ali, R., Kanter, L., Orrego, A., Sandstedt, B., Sveinbjornsson, B. , Johnsen, J.I., Kogner, P., Ahrlund-Richter, L. Modeling of neuroblastoma growth in a human embryonic microenvironment adds emphasis to clinical relevance. Submitted" @default.
- W61151033 created "2016-06-24" @default.
- W61151033 creator A5013749925 @default.
- W61151033 date "2010-05-07" @default.
- W61151033 modified "2023-09-24" @default.
- W61151033 title "OPTIMIZATION AND VALIDATION OF A SPECIES- SPECIFIC IN VIVO APPROACH FOR STUDIES ON GROWTH AND PROGRESSION OF NEURAL CREST DERIVED TUMOURS" @default.
- W61151033 cites W105646620 @default.
- W61151033 cites W1216250015 @default.
- W61151033 cites W1513127266 @default.
- W61151033 cites W1516721515 @default.
- W61151033 cites W1520596966 @default.
- W61151033 cites W1532405552 @default.
- W61151033 cites W1532790643 @default.
- W61151033 cites W1539103037 @default.
- W61151033 cites W1542914978 @default.
- W61151033 cites W1561598641 @default.
- W61151033 cites W1565566882 @default.
- W61151033 cites W1566579330 @default.
- W61151033 cites W1570458334 @default.
- W61151033 cites W1572114222 @default.
- W61151033 cites W1577838670 @default.
- W61151033 cites W1585587869 @default.
- W61151033 cites W1599207756 @default.
- W61151033 cites W1603508604 @default.
- W61151033 cites W1661391341 @default.
- W61151033 cites W1665436044 @default.
- W61151033 cites W1806182344 @default.
- W61151033 cites W1894858966 @default.
- W61151033 cites W1902445142 @default.
- W61151033 cites W1903297883 @default.
- W61151033 cites W1923913903 @default.
- W61151033 cites W1951128322 @default.
- W61151033 cites W1951705554 @default.
- W61151033 cites W1963879539 @default.
- W61151033 cites W1968276638 @default.
- W61151033 cites W1970832400 @default.
- W61151033 cites W1971512164 @default.
- W61151033 cites W1972838002 @default.
- W61151033 cites W1978139448 @default.
- W61151033 cites W1978773985 @default.
- W61151033 cites W1979339696 @default.
- W61151033 cites W1981088384 @default.
- W61151033 cites W1982501879 @default.
- W61151033 cites W1982620025 @default.
- W61151033 cites W1982903815 @default.
- W61151033 cites W1983673827 @default.
- W61151033 cites W1985368135 @default.
- W61151033 cites W1986522151 @default.
- W61151033 cites W1986808310 @default.
- W61151033 cites W1987564805 @default.
- W61151033 cites W1988865085 @default.
- W61151033 cites W1990437124 @default.
- W61151033 cites W1991711413 @default.
- W61151033 cites W1992252639 @default.
- W61151033 cites W1993610674 @default.
- W61151033 cites W1994203984 @default.
- W61151033 cites W1995827857 @default.
- W61151033 cites W1996659151 @default.
- W61151033 cites W1997889534 @default.
- W61151033 cites W1999872884 @default.
- W61151033 cites W2000146676 @default.
- W61151033 cites W2000985656 @default.
- W61151033 cites W2002179012 @default.
- W61151033 cites W2002508731 @default.
- W61151033 cites W2003240618 @default.
- W61151033 cites W2003464973 @default.
- W61151033 cites W2005883417 @default.
- W61151033 cites W2009263545 @default.
- W61151033 cites W2009644698 @default.
- W61151033 cites W2009727012 @default.
- W61151033 cites W2010598092 @default.
- W61151033 cites W2010978319 @default.
- W61151033 cites W2012434275 @default.
- W61151033 cites W2013818100 @default.
- W61151033 cites W2014231393 @default.
- W61151033 cites W2015086441 @default.
- W61151033 cites W2016315311 @default.
- W61151033 cites W2016361087 @default.
- W61151033 cites W2017452459 @default.
- W61151033 cites W2021464205 @default.
- W61151033 cites W2022354436 @default.
- W61151033 cites W2024973490 @default.
- W61151033 cites W2025761890 @default.
- W61151033 cites W2025903846 @default.
- W61151033 cites W2026084160 @default.
- W61151033 cites W2027142644 @default.
- W61151033 cites W2027554143 @default.
- W61151033 cites W2027779389 @default.
- W61151033 cites W2030684277 @default.
- W61151033 cites W2031132185 @default.
- W61151033 cites W2032150619 @default.
- W61151033 cites W2033191003 @default.
- W61151033 cites W2033284482 @default.
- W61151033 cites W2033448771 @default.
- W61151033 cites W2034516953 @default.
- W61151033 cites W2034683528 @default.
- W61151033 cites W2035282066 @default.
- W61151033 cites W2038440293 @default.
- W61151033 cites W2038723730 @default.
- W61151033 cites W2041566213 @default.